Try our beta test site
453 studies found for:    Open Studies | "Stomach Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal Testing
Conditions: Colorectal Cancer;   Stomach Disease
Interventions: Other: FIT(Eiken OC-Sensor) Two-day sampling;   Other: FIT(Eiken OC-Sensor) One-year interval;   Other: FIT(Eiken OC-Sensor) One-day sampling;   Other: FIT(Eiken OC-Sensor) Two-year interval;   Other: HpSA (Firstep Helicobacter pylori Antigen Rapid Test)
2 Not yet recruiting A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy
Condition: NSAID-induced Gastropathy
Interventions: Drug: bismuth tripotassium dicitrate;   Drug: pantoprazole
3 Recruiting Diagnosis of Gastric Lesions With Na-nose
Condition: Stomach Diseases
Intervention:
4 Recruiting Gastric Preparation of Magnetic-controlled Capsule Endoscopy
Condition: Stomach Diseases
Interventions: Other: clear water;   Drug: simethicone;   Drug: simethicone combined with pronase
5 Not yet recruiting Linked Color Imaging Based CMV Diagnosis for Gastric Mucosal Lesions
Condition: Gastric Disease
Interventions: Procedure: WLE and then LCI;   Procedure: LCI and then WLE
6 Not yet recruiting Gastric Emptying: in Vivo Studies in Healthy Volunteers
Condition: Gastric Disease
Intervention: Radiation: Gastric emptying scintigraphy using 99mTc-DTPA
7 Not yet recruiting Pembrolizumab, Radiotherapy, and Chemotherapy in Neoadjuvant Treatment of Malignant Esophago-gastric Diseases (PROCEED)
Condition: Locally Advanced Esophageal and Gastric Cancers (EGC)
Intervention: Drug: Pembrolizumab
8 Recruiting The Usefulness of Self-expandable Metal Stents(SEMS) for Malignant Gastric Outlet Obstruction: a Prospective Study Using New Designed Stents
Condition: Malignant Gastric Outlet Obstruction
Interventions: Device: Winged stent (partially covered);   Device: Winged stent (uncovered)
9 Not yet recruiting A Multi-center Study for Eradication of Helicobacter Pylori With Triple Therapy Using Clarithromycin
Condition: Gastritis
Interventions: Device: The results of clarithromycin susceptibility test of H. pylori isolates;   Device: Computer generated random number, randomly assigned into groups;   Device: The result of 13C-urea breath test of patient in 7days/10days/14days treatment groups
10 Not yet recruiting Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication
Condition: Gastritis Associated With Helicobacter Pylori
Interventions: Drug: vonoprazan 20 mg bid;   Drug: Amoxicillin 500 mg tid;   Drug: Amoxicillin 750 mg bid;   Drug: Clarithromycin 200 mg bid;   Drug: Metronidazole 250 mg bid
11 Recruiting A Multi-center Study for Eradication of Refractory Helicobacter Pylori
Condition: Gastritis
Interventions: Device: The result of H pylori culture based on gram staining and enzyme activity testing;   Device: The result of 13C-urea breath test after treatment based on the selection of clarithromycin, levofloxacin, metronidazole, amoxicillin,tetracycline,furazolidone and the dose of esomeprazole;   Device: The result of Amoxicillin resistance in vitro based on antibiotic susceptibility testing
12 Recruiting Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori
Condition: Helicobacter-associated Gastritis
Interventions: Drug: Nitazoxanide;   Drug: Metronidazole(MTZ);   Drug: Omeprazole;   Drug: Clarithromycin;   Drug: Levofloxacin;   Drug: Doxicycline
13 Recruiting Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis
Condition: Gastritis
Interventions: Drug: GC6101A 37.5mg;   Drug: GC6101A 75mg;   Drug: GC6101A 150mg;   Drug: Placebo
14 Recruiting Domperidone for Refractory Gastrointestinal Disorders
Condition: Gastroparesis
Intervention: Drug: Domperidone
15 Recruiting Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Radical Gastrectomy for Gastric Cancer
Conditions: Gastric Cancer;   Gastrointestinal Disease
Interventions: Dietary Supplement: Hou Gu Mi Xi;   Other: placebo
16 Recruiting UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD
Condition: Peptic Ulcer
Interventions: Procedure: endoscopic adhesive powder;   Drug: epinephrine;   Device: Endoscopic Wound Dressing (Next Biomedical)
17 Not yet recruiting The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis
Condition: Chronic Atrophic Gastritis
Interventions: Drug: Talcid®;   Drug: Chinese medicine prescription;   Drug: Placebo;   Drug: Compound Azimtamide Entieric-coated Tablets
18 Not yet recruiting Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Gastric Inflammation Patients
Condition: Acute and Chronic Gastric Inflammation Patients
Interventions: Drug: DW-3101_150mg;   Drug: DW-3101_300mg;   Drug: DW-3101_600mg;   Drug: Placebo
19 Recruiting Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea
Condition: Atrophic Gastritis
Intervention: Drug: pepsinogen and gastrin
20 Not yet recruiting Naloxegol for Opioid-Related Gastroparesis
Conditions: Gastroparesis;   Opioid Use
Interventions: Drug: Naloxegol 25 MG Oral Tablet [Movantik];   Drug: Placebo Oral Tablet

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.